Skip to main content
Signal8

Fisher Stewart

SEC insider (Form 3/4/5 filer). CIK 0001824863. Chief Scientific Officer at C4 Therapeutics, Inc. (CCCC). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2024. Located in WATERTOWN, MA.

Companies Fisher Stewart has filed insider reports for

  • C4 Therapeutics, Inc. (CCCC): Officer, Chief Scientific Officer
Fisher Stewart profile photo

Fisher Stewart

CIK: 0001824863

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (50.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

C4 Therapeutics, Inc. logo
CCCC

C4 Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • C4 Therapeutics, Inc. logo
    CCCC

    C4 Therapeutics, Inc.

    Sep 16, 2024
    Exercise
    Direct
    2.3K shares-
  • C4 Therapeutics, Inc. logo
    CCCC

    C4 Therapeutics, Inc.

    Sep 16, 2024
    Tax Payment
    Direct
    661 shares at avg. $6.36$4K

1-2 of 2